FDA Inspection 1020360 — Corcym Canada Corp.
The FDA completed an inspection of Corcym Canada Corp. on April 13, 2017 in Burnaby. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- April 13, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Burnaby (Canada)
Additional Details
Postmarket Audit Inspections